Full Text View
Tabular View
No Study Results Posted
Related Studies
Targeting Inflammation Using Salsalate in CardioVascular Disease (TINSAL-CVD)
This study is ongoing, but not recruiting participants.
Study NCT00624923   Information provided by Joslin Diabetes Center

First Received on February 19, 2008.   Last Updated on July 25, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Artery Disease
Overweight
Additional conditions recognized in this trial
Cardiovascular Diseases
Coronary Disease
Inflammation
Myocardial Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Body Weight
Heart Diseases
Pathologic Processes
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
Salsalate
Placebo
Additional drug interventions recognized in this trial
Salicylsalicylic acid
Sodium Salicylate
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Allison Goldfine
Beth Israel Deaconess Medical Center
Tufts Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services